Systematic review and meta-analysis of randomised controlled clinical trial evidence refutes relationship between pharmacotherapy with angiotensin-receptor blockers and an increased risk of cancer
Author:
Publisher
Elsevier BV
Subject
Internal Medicine
Reference81 articles.
1. Hemmstoffe des Renin-Angiotensin-Systems;Anlauf,2016
2. Barmer GEK Arzneimittelreport 2016;Grandt;Schriftenreihe zur Gesundheitsanalyse,2016
3. An FDA overview of rodent carcinogenicity studies of angiotensin II AT-1 receptor blockers: pulmonary adenomas and carcinomas;Link;Regul Toxicol Pharmacol,2014
4. Angiotensin receptors: a new role in cancer?;Deshayes;Trends Endocrinol Metab,2005
5. Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials;Sipahi;Lancet Oncol,2010
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The renin-angiotensin-aldosterone system (RAAS) signaling pathways and cancer: foes versus allies;Cancer Cell International;2023-10-27
2. 2022 Update on Prostate Cancer Epidemiology and Risk Factors—A Systematic Review;European Urology;2023-08
3. Angiotensin Receptor Blocker Associated with a Decreased Risk of Lung Cancer: An Updated Meta-Analysis;Journal of Personalized Medicine;2023-01-29
4. Mini-review: Angiotensin- converting enzyme 1 (ACE1) and the impact for diseases such as Alzheimer’s disease, sarcopenia, cancer, and COVID-19;Frontiers in Aging;2023-01-23
5. Concentrations of Transition Metal Ions in Rat Lungs after Tobacco Smoke Exposure and Treatment with His-Leu Dipeptide;Molecules;2023-01-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3